Antioxidants (Sep 2021)

Oxidative Stress in Optic Neuropathies

  • Berta Sanz-Morello,
  • Hamid Ahmadi,
  • Rupali Vohra,
  • Sarkis Saruhanian,
  • Kristine Karla Freude,
  • Steffen Hamann,
  • Miriam Kolko

DOI
https://doi.org/10.3390/antiox10101538
Journal volume & issue
Vol. 10, no. 10
p. 1538

Abstract

Read online

Increasing evidence indicates that changes in the redox system may contribute to the pathogenesis of multiple optic neuropathies. Optic neuropathies are characterized by the neurodegeneration of the inner-most retinal neurons, the retinal ganglion cells (RGCs), and their axons, which form the optic nerve. Often, optic neuropathies are asymptomatic until advanced stages, when visual impairment or blindness is unavoidable despite existing treatments. In this review, we describe systemic and, whenever possible, ocular redox dysregulations observed in patients with glaucoma, ischemic optic neuropathy, optic neuritis, hereditary optic neuropathies (i.e., Leber’s hereditary optic neuropathy and autosomal dominant optic atrophy), nutritional and toxic optic neuropathies, and optic disc drusen. We discuss aspects related to anti/oxidative stress biomarkers that need further investigation and features related to study design that should be optimized to generate more valuable and comparable results. Understanding the role of oxidative stress in optic neuropathies can serve to develop therapeutic strategies directed at the redox system to arrest the neurodegenerative processes in the retina and RGCs and ultimately prevent vision loss.

Keywords